Kyoto, Japan

Hiroji Yanamoto

This inventor holds 1 USPTO granted patent. Top assignee: Torii & Co., Ltd.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroji Yanamoto. Retrieved from https://idiyas.com/inventor/hiroji-yanamoto-9334b0td

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroji Yanamoto: Innovator in Cerebrovascular Treatment

Introduction

Hiroji Yanamoto is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of cerebrovascular conditions. His innovative approach has led to the development of a unique pharmaceutical composition aimed at improving health outcomes for mammals.

Latest Patents

Yanamoto holds a patent for an "Agent for treatment of cerebrovascular contraction." This patent describes a method for treating cerebrovascular contraction in mammals through the administration of a pharmaceutical composition containing a p-guanidinobenzoic acid derivative. The effective ingredient is represented by a specific formula, which includes a pharmaceutically acceptable salt and carrier.

Career Highlights

Hiroji Yanamoto is associated with Torii & Co., Ltd., a reputable company known for its commitment to pharmaceutical innovation. His work at the company has allowed him to focus on developing treatments that address critical health issues, showcasing his dedication to improving patient care.

Collaborations

Yanamoto collaborates with Haruhiko Kikuchi, a fellow innovator in the field. Their partnership exemplifies the importance of teamwork in advancing medical research and developing effective treatments.

Conclusion

Hiroji Yanamoto's contributions to cerebrovascular treatment highlight his role as a key inventor in the pharmaceutical industry. His innovative patent and collaboration with colleagues reflect a commitment to enhancing health outcomes through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…